Pα+ Psychedelic Bulletin #150: Drug Development and Research Updates Post published:November 29, 2023 Post category:Psychedelic Bulletin/Pα+
Pα+ Psychedelic Bulletin #149: Worldwide Psychedelic Policy Developments Post published:November 17, 2023 Post category:Psychedelic Bulletin/Pα+
Psychedelic Bulletin #148 (Pα+) Post published:November 3, 2023 Post category:Psychedelic Bulletin/Pα+
Psychedelic Bulletin #147: Newsom Vetoes Psychedelic Decrim. in CA; At-Home Ketamine Gets a Lifeline and a Warning; Drug Development Updates from GH, atai, Cybin; and more Post published:October 17, 2023 Post category:Psychedelic Bulletin
Psychedelic Bulletin #146: Numinus Drops Lab, Consolidates Clinics; Study Suggests DMT Safe and Effective Alongside SSRI; Preprint Calls Intracellular Theory of Psychedelic-induced Neuroplasticity Into Question; A Cole Memo for Psychedelics? Post published:September 29, 2023 Post category:Psychedelic Bulletin
Psychedelic Bulletin #145: MAPS’ Second Phase 3 Study Published; EMA’s New Draft Guideline on Depression Drug Dev Includes Psychedelics; California’s Decrim. Bill Goes to Governor Post published:September 19, 2023 Post category:Psychedelic Bulletin
Psychedelic Bulletin #144: Otsuka to Buy Mindset; Responses to FDA Draft Guidance; Cybin to Acquire Small Pharma; Usona Publishes Phase 2 Study Post published:August 31, 2023 Post category:Psychedelic Bulletin
Psychedelic Bulletin #143: Trademark Filing Reveals Potential Brand Name for MDMA; DEA “Open to Considering” Special Registration for Controlled Substances via Telemedicine; Professional Practice Guidelines for PAT; Sage’s Zuranolone Rejection Post published:August 11, 2023 Post category:Psychedelic Bulletin
Psychedelic Bulletin #142: Terran’s IP Portfolio; AMA Advocates Against Non-Medical Psychedelics; Couple Receives First Psilocybin Services in Oregon; Mass. Ballot Measure Ramps Up; NIDA and NIMH Directors Opine Post published:July 31, 2023 Post category:Psychedelic Bulletin
Psychedelic Bulletin #141: Terran’s 4-OH-DiPT Prodrug Patent App.; Generic Ketamine Appears Effective for TRD; VA/DoD Guideline Reviews Psychedelics Post published:July 17, 2023 Post category:Psychedelic Bulletin